首页 > 最新文献

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science最新文献

英文 中文
Not Fully Synthetic: LLM-based Hybrid Approaches Towards Privacy-Preserving Clinical Note Sharing. 不完全合成:基于法学硕士的混合方法对隐私保护临床笔记共享。
Atiquer Rahman Sarkar, Yao-Shun Chuang, Xiaoqian Jiang, Noman Mohammed

The publication and sharing of clinical notes are crucial for healthcare research and innovation. However, privacy regulations such as HIPAA and GDPR pose significant challenges. While de-identification techniques aim to remove protected health information, they often fall short of achieving complete privacy protection. Similarly, the current state of synthetic clinical note generation can lack nuance and content coverage. To address these limitations, we propose an approach that combines de-identification, filtration, and synthetic clinical note generation. Variations of this approach currently retain 36%-61% of the original note's content and fill the remaining gaps using an LLM, ensuring high information coverage. We also evaluated the de-identification performance of the hybrid notes, demonstrating that they surpass or at least match the standalone de-identification methods. Our results show that hybrid notes can maintain patient privacy while preserving the richness of clinical data. This approach offers a promising solution for safe and effective data sharing, encouraging further research.

临床记录的发布和共享对于医疗保健研究和创新至关重要。然而,HIPAA和GDPR等隐私法规带来了重大挑战。虽然去识别技术旨在删除受保护的健康信息,但它们往往无法实现完全的隐私保护。同样,合成临床记录生成的当前状态可能缺乏细微差别和内容覆盖。为了解决这些限制,我们提出了一种结合去识别、过滤和合成临床记录生成的方法。目前,这种方法的变体保留了原始笔记内容的36%-61%,并使用LLM填补了剩余的空白,确保了高信息覆盖率。我们还评估了混合笔记的去识别性能,证明它们超过或至少与独立的去识别方法相匹配。我们的研究结果表明,混合笔记可以在保留临床数据丰富性的同时维护患者隐私。这种方法为安全有效的数据共享提供了一个有希望的解决方案,鼓励进一步的研究。
{"title":"Not Fully Synthetic: LLM-based Hybrid Approaches Towards Privacy-Preserving Clinical Note Sharing.","authors":"Atiquer Rahman Sarkar, Yao-Shun Chuang, Xiaoqian Jiang, Noman Mohammed","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The publication and sharing of clinical notes are crucial for healthcare research and innovation. However, privacy regulations such as HIPAA and GDPR pose significant challenges. While de-identification techniques aim to remove protected health information, they often fall short of achieving complete privacy protection. Similarly, the current state of synthetic clinical note generation can lack nuance and content coverage. To address these limitations, we propose an approach that combines de-identification, filtration, and synthetic clinical note generation. Variations of this approach currently retain 36%-61% of the original note's content and fill the remaining gaps using an LLM, ensuring high information coverage. We also evaluated the de-identification performance of the hybrid notes, demonstrating that they surpass or at least match the standalone de-identification methods. Our results show that hybrid notes can maintain patient privacy while preserving the richness of clinical data. This approach offers a promising solution for safe and effective data sharing, encouraging further research.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"441-450"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reusable Generic Clinical Decision Support System Module for Immunization Recommendations in Resource-Constraint Settings. 可重复使用的通用临床决策支持系统模块的免疫建议在资源限制的设置。
Samuil Orlioglu, Akash Shanmugan Boobalan, Kojo Abanyie, Richard D Boyce, Hua Min, Yang Gong, Dean F Sittig, Paul Biondich, Adam Wright, Christian Nøhr, Timothy Law, David Robinson, Arild Faxvaag, Nina Hubig, Ronald Gimbel, Lior Rennert, Xia Jing

Clinical decision support systems (CDSS) are routinely employed in clinical settings to improve quality of care, ensure patient safety, and deliver consistent medical care. However, rule-based CDSS, currently available, do not feature reusable rules. In this study, we present CDSS with reusable rules. Our solution includes a common CDSS module, electronic medical record (EMR) specific adapters, CDSS rules written in the clinical quality language (CQL) (derived from CDC immunization recommendations), and patient records in fast healthcare interoperability resources (FHIR) format. The proposed CDSS is entirely browser-based and reachable within the user's EMR interface at the client-side. This helps to avoid the transmission ofpatient data and privacy breaches. Additionally, we propose to provide means of managing and maintaining CDSS rules to allow the end users to modify them independently. Successful implementation and deployment were achieved in OpenMRS and OpenEMR during initial testing.

临床决策支持系统(CDSS)通常用于临床环境,以提高护理质量,确保患者安全,并提供一致的医疗服务。然而,目前可用的基于规则的CDSS不具有可重用规则的特性。在本研究中,我们提出了具有可重用规则的CDSS。我们的解决方案包括一个通用的CDSS模块、电子医疗记录(EMR)特定适配器、用临床质量语言(CQL)编写的CDSS规则(源自CDC免疫建议)以及快速医疗保健互操作性资源(FHIR)格式的患者记录。建议的CDSS完全基于浏览器,并且可以在客户端的用户EMR界面中访问。这有助于避免患者数据的传输和隐私泄露。此外,我们建议提供管理和维护CDSS规则的方法,以允许最终用户独立地修改它们。在初始测试期间,在OpenMRS和openenemr中实现了成功的实现和部署。
{"title":"Reusable Generic Clinical Decision Support System Module for Immunization Recommendations in Resource-Constraint Settings.","authors":"Samuil Orlioglu, Akash Shanmugan Boobalan, Kojo Abanyie, Richard D Boyce, Hua Min, Yang Gong, Dean F Sittig, Paul Biondich, Adam Wright, Christian Nøhr, Timothy Law, David Robinson, Arild Faxvaag, Nina Hubig, Ronald Gimbel, Lior Rennert, Xia Jing","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Clinical decision support systems (CDSS) are routinely employed in clinical settings to improve quality of care, ensure patient safety, and deliver consistent medical care. However, rule-based CDSS, currently available, do not feature reusable rules. In this study, we present CDSS with reusable rules. Our solution includes a common CDSS module, electronic medical record (EMR) specific adapters, CDSS rules written in the clinical quality language (CQL) (derived from CDC immunization recommendations), and patient records in fast healthcare interoperability resources (FHIR) format. The proposed CDSS is entirely browser-based and reachable within the user's EMR interface at the client-side. This helps to avoid the transmission ofpatient data and privacy breaches. Additionally, we propose to provide means of managing and maintaining CDSS rules to allow the end users to modify them independently. Successful implementation and deployment were achieved in OpenMRS and OpenEMR during initial testing.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"395-404"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating a conceptual consent permission model from the informed consent ontology for software application execution. 从知情同意本体中集成概念同意许可模型,用于软件应用程序的执行。
Muhammad Tuan Amith, Yongqun He, Elise Smith, Marceline Harris, Frank Manion, Cui Tao

We developed a simulated process to show a software implementation to facilitate an approach to integrate the Informed Consent Ontology, a reference ontology of informed consent information, to express implicit description and implement conceptual permission from informed consent life cycle. An early study introduced an experimental method to use Semantic Web Rule Language (SWRL) to describe and represent permissions to computational deduce more information from the Informed Consent Ontology (ICO), demonstrated by the use of the All of Us informed consent documents. We show how incomplete information in informed consent documents can be elucidated using a computational model of permissions toward health information technology that integrates ontologies. Future goals entail applying our computational approach for specific sub-domains of the informed consent life cycle, specifically for vaccine informed consent.

我们开发了一个模拟过程来展示软件实现,以促进集成知情同意本体(知情同意信息的参考本体)的方法,以表达隐含描述并实现知情同意生命周期的概念许可。一项早期研究引入了一种实验方法,使用语义Web规则语言(SWRL)来描述和表示权限,从而从知情同意本体(ICO)中计算推断出更多信息,并通过使用All of Us知情同意文档进行演示。我们展示了如何使用集成本体的健康信息技术许可计算模型来阐明知情同意文件中的不完整信息。未来的目标需要将我们的计算方法应用于知情同意生命周期的特定子领域,特别是疫苗知情同意。
{"title":"Integrating a conceptual consent permission model from the informed consent ontology for software application execution.","authors":"Muhammad Tuan Amith, Yongqun He, Elise Smith, Marceline Harris, Frank Manion, Cui Tao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We developed a simulated process to show a software implementation to facilitate an approach to integrate the Informed Consent Ontology, a reference ontology of informed consent information, to express implicit description and implement conceptual permission from informed consent life cycle. An early study introduced an experimental method to use Semantic Web Rule Language (SWRL) to describe and represent permissions to computational deduce more information from the Informed Consent Ontology (ICO), demonstrated by the use of the All of Us informed consent documents. We show how incomplete information in informed consent documents can be elucidated using a computational model of permissions toward health information technology that integrates ontologies. Future goals entail applying our computational approach for specific sub-domains of the informed consent life cycle, specifically for vaccine informed consent.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"46-55"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization of an AI-Powered Chatbot for Enhancing Oral Cancer Awareness among African Americans: Expert Feedback on Usability. 利用人工智能聊天机器人提高非裔美国人对口腔癌的认识:专家对可用性的反馈。
Nour Abosamak, Asmaa Namoos, Janina Golob Deeb, Tamas Gal

Oral and oropharyngeal cancers disproportionately affect Black Americans, contributing to significant healthcare disparities due to late-stage diagnoses and limited awareness. AI-powered chatbots have the potential to address these challenges by offering scalable, interactive, and personalized educational tools. This study evaluated the usability and accuracy of a Large Language Model-powered chatbot prototype under a Retrieval Augmented Generation framework designed to enhance oral cancer awareness, using a mixed-methods approach with six technical and clinical experts. Usability and accuracy were rated positively by 83.3% of the experts, with median scores of 6.65 and 7.67, respectively. Key areas for improvement included providing a clear introduction, simplifying the interface, addressing accessibility issues, and incorporating features like next-question suggestions, downloadable chats, and reference links. While content accuracy was well-received, gaps in conversational flow and technical term definitions were noted. These findings highlight the chatbot's potential to improve health literacy and reduce disparities.

口腔癌和口咽癌对美国黑人的影响不成比例,由于晚期诊断和意识有限,造成了显著的医疗差距。人工智能聊天机器人有潜力通过提供可扩展、互动和个性化的教育工具来解决这些挑战。本研究与六位技术和临床专家采用混合方法,在检索增强生成框架下评估了大型语言模型驱动的聊天机器人原型的可用性和准确性,该框架旨在提高口腔癌的认识。83.3%的专家对可用性和准确性给出了肯定的评价,中位数分别为6.65分和7.67分。需要改进的关键领域包括提供清晰的介绍、简化界面、解决可访问性问题,以及合并下一个问题建议、可下载聊天和参考链接等功能。虽然内容的准确性受到好评,但注意到会话流程和技术术语定义方面的差距。这些发现突出了聊天机器人在提高健康素养和减少差距方面的潜力。
{"title":"Utilization of an AI-Powered Chatbot for Enhancing Oral Cancer Awareness among African Americans: Expert Feedback on Usability.","authors":"Nour Abosamak, Asmaa Namoos, Janina Golob Deeb, Tamas Gal","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Oral and oropharyngeal cancers disproportionately affect Black Americans, contributing to significant healthcare disparities due to late-stage diagnoses and limited awareness. AI-powered chatbots have the potential to address these challenges by offering scalable, interactive, and personalized educational tools. This study evaluated the usability and accuracy of a Large Language Model-powered chatbot prototype under a Retrieval Augmented Generation framework designed to enhance oral cancer awareness, using a mixed-methods approach with six technical and clinical experts. Usability and accuracy were rated positively by 83.3% of the experts, with median scores of 6.65 and 7.67, respectively. Key areas for improvement included providing a clear introduction, simplifying the interface, addressing accessibility issues, and incorporating features like next-question suggestions, downloadable chats, and reference links. While content accuracy was well-received, gaps in conversational flow and technical term definitions were noted. These findings highlight the chatbot's potential to improve health literacy and reduce disparities.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"42-45"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DIRI: Adversarial Patient Reidentification with Large Language Models for Evaluating Clinical Text Anonymization. 使用大型语言模型评估临床文本匿名化的对抗性患者再识别。
John X Morris, Thomas R Campion, Sri Laasya Nutheti, Yifan Peng, Akhil Raj, Ramin Zabih, Curtis L Cole

Sharing protected health information (PHI) is critical for furthering biomedical research. Before data can be distributed, practitioners often perform deidentification to remove any PHI contained in the text. Contemporary deidentification methods are evaluated on highly saturated datasets (tools achieve near-perfect accuracy) which may not reflect the full variability or complexity of real-world clinical text and annotating them is resource intensive, which is a barrier to real-world applications. To address this gap, we developed an adversarial approach using a large language model (LLM) to re-identify the patient corresponding to a redacted clinical note and evaluated the performance with a novel De-Identification/Re-Identification (DIRI) method. Our method uses a large language model to reidentify the patient corresponding to a redacted clinical note. We demonstrate our method on medical data from Weill Cornell Medicine anonymized with three deidentification tools: rule-based Philter and two deep-learning-based models, BiLSTM-CRF and ClinicalBERT. Although ClinicalBERT was the most effective, masking all identified PII, our tool still reidentified 9% of clinical notes Our study highlights significant weaknesses in current deidentification technologies while providing a tool for iterative development and improvement.

共享受保护的健康信息(PHI)对于进一步开展生物医学研究至关重要。在数据可以分发之前,从业者通常执行去识别以删除文本中包含的任何PHI。当代去识别方法是在高度饱和的数据集上进行评估的(工具达到近乎完美的准确性),这些数据集可能无法反映真实世界临床文本的全部可变性或复杂性,并且注释它们是资源密集型的,这是现实世界应用的障碍。为了解决这一差距,我们开发了一种使用大型语言模型(LLM)的对抗性方法,根据编辑的临床记录重新识别患者,并使用一种新的去识别/重新识别(DIRI)方法评估其性能。我们的方法使用大型语言模型来重新识别与编辑的临床记录相对应的患者。我们使用三种去识别工具(基于规则的Philter和两个基于深度学习的模型,BiLSTM-CRF和ClinicalBERT)对来自威尔康奈尔医学的医疗数据进行了匿名化处理,展示了我们的方法。虽然ClinicalBERT是最有效的,掩盖了所有已识别的PII,但我们的工具仍然重新识别了9%的临床记录。我们的研究强调了当前去识别技术的重大弱点,同时提供了迭代开发和改进的工具。
{"title":"DIRI: Adversarial Patient Reidentification with Large Language Models for Evaluating Clinical Text Anonymization.","authors":"John X Morris, Thomas R Campion, Sri Laasya Nutheti, Yifan Peng, Akhil Raj, Ramin Zabih, Curtis L Cole","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Sharing protected health information (PHI) is critical for furthering biomedical research. Before data can be distributed, practitioners often perform deidentification to remove any PHI contained in the text. Contemporary deidentification methods are evaluated on highly saturated datasets (tools achieve near-perfect accuracy) which may not reflect the full variability or complexity of real-world clinical text and annotating them is resource intensive, which is a barrier to real-world applications. To address this gap, we developed an adversarial approach using a large language model (LLM) to re-identify the patient corresponding to a redacted clinical note and evaluated the performance with a novel De-Identification/Re-Identification (DIRI) method. Our method uses a large language model to reidentify the patient corresponding to a redacted clinical note. We demonstrate our method on medical data from Weill Cornell Medicine anonymized with three deidentification tools: rule-based Philter and two deep-learning-based models, BiLSTM-CRF and ClinicalBERT. Although ClinicalBERT was the most effective, masking all identified PII, our tool still reidentified 9% of clinical notes Our study highlights significant weaknesses in current deidentification technologies while providing a tool for iterative development and improvement.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"355-364"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150728/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Natural Product-Drug Interactions with Knowledge Graph Embeddings. 利用知识图嵌入预测天然产物-药物相互作用。
Sanya B Taneja, Israel O Dilán-Pantojas, Richard D Boyce

Natural product-drug interactions (NPDIs) occurring due to concomitant exposure to botanical products and prescription drug therapies could lead to adverse events or reduced treatment efficacy. To better understand and address potential safety concerns, researchers investigate the underlying NPDI mechanisms using in vitro and clinical studies. Given that natural products are complex mixtures of compounds that are often not well characterized, it is important to advance computational methods for novel NPDI research. Biomedical knowledge graphs (KGs) can aid in identifying potential mechanisms to support such research efforts. We evaluated the ability of several KG embedding methods to improve NPDI prediction on NP-KG, a large-scale, heterogeneous, biomedical KG. We found that the ComplEx model outperformed other KG embedding approaches in both intrinsic and extrinsic evaluations. Future work will focus on utilizing the embeddings to identify underlying mechanisms of novel, potential NPDIs.

由于同时暴露于植物产品和处方药治疗而发生的天然产物-药物相互作用(NPDIs)可能导致不良事件或降低治疗效果。为了更好地理解和解决潜在的安全问题,研究人员通过体外和临床研究调查了潜在的NPDI机制。鉴于天然产物是复杂的化合物混合物,通常不能很好地表征,因此为新型NPDI研究提出计算方法是很重要的。生物医学知识图谱(KGs)有助于确定支持此类研究工作的潜在机制。我们评估了几种KG嵌入方法提高NP-KG(大规模、异构、生物医学KG) NPDI预测的能力。我们发现ComplEx模型在内在和外在评价方面都优于其他KG嵌入方法。未来的工作将集中于利用嵌入来确定新的潜在npd的潜在机制。
{"title":"Predicting Natural Product-Drug Interactions with Knowledge Graph Embeddings.","authors":"Sanya B Taneja, Israel O Dilán-Pantojas, Richard D Boyce","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Natural product-drug interactions (NPDIs) occurring due to concomitant exposure to botanical products and prescription drug therapies could lead to adverse events or reduced treatment efficacy. To better understand and address potential safety concerns, researchers investigate the underlying NPDI mechanisms using in vitro and clinical studies. Given that natural products are complex mixtures of compounds that are often not well characterized, it is important to advance computational methods for novel NPDI research. Biomedical knowledge graphs (KGs) can aid in identifying potential mechanisms to support such research efforts. We evaluated the ability of several KG embedding methods to improve NPDI prediction on NP-KG, a large-scale, heterogeneous, biomedical KG. We found that the ComplEx model outperformed other KG embedding approaches in both intrinsic and extrinsic evaluations. Future work will focus on utilizing the embeddings to identify underlying mechanisms of novel, potential NPDIs.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"556-565"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150722/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SmartState: An Automated Research Protocol Adherence System. SmartState:一个自动化的研究协议遵守系统。
Samuel E Armstrong, Mitchell A Klusty, Aaron D Mullen, Jeffery C Talbert, Cody Bumgardner

Developing and enforcing study protocols is crucial in medical research, especially as interactions with participants become more intricate. Traditional rules-based systems struggle to provide the automation and flexibility required for real-time, personalized data collection. We introduce SmartState, a state-based system designed to act as a personal agent for each participant, continuously managing and tracking their unique interactions. Unlike traditional reporting systems, SmartState enables real-time, automated data collection with minimal oversight. By integrating large language models to distill conversations into structured data, SmartState reduces errors and safeguards data integrity through built-in protocol and participant auditing. We demonstrate its utility in research trials involving time-dependent participant interactions, addressing the increasing need for reliable automation in complex clinical studies.

制定和执行研究方案在医学研究中至关重要,尤其是在与参与者的互动变得更加复杂的情况下。传统的基于规则的系统难以提供实时、个性化数据收集所需的自动化和灵活性。我们推出了SmartState,这是一个基于状态的系统,旨在充当每个参与者的个人代理,持续管理和跟踪他们独特的互动。与传统的报告系统不同,SmartState能够以最小的监督进行实时、自动化的数据收集。通过集成大型语言模型将对话提炼成结构化数据,SmartState通过内置协议和参与者审计来减少错误并保护数据完整性。我们展示了它在涉及时间依赖性参与者相互作用的研究试验中的效用,解决了复杂临床研究中对可靠自动化的日益增长的需求。
{"title":"SmartState: An Automated Research Protocol Adherence System.","authors":"Samuel E Armstrong, Mitchell A Klusty, Aaron D Mullen, Jeffery C Talbert, Cody Bumgardner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Developing and enforcing study protocols is crucial in medical research, especially as interactions with participants become more intricate. Traditional rules-based systems struggle to provide the automation and flexibility required for real-time, personalized data collection. We introduce SmartState, a state-based system designed to act as a personal agent for each participant, continuously managing and tracking their unique interactions. Unlike traditional reporting systems, SmartState enables real-time, automated data collection with minimal oversight. By integrating large language models to distill conversations into structured data, SmartState reduces errors and safeguards data integrity through built-in protocol and participant auditing. We demonstrate its utility in research trials involving time-dependent participant interactions, addressing the increasing need for reliable automation in complex clinical studies.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"56-64"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major Cardiovascular and Renal Complications in IgA Vasculitis: Insights from a Federated Health Research Network. IgA血管炎的主要心血管和肾脏并发症:来自联邦健康研究网络的见解。
Arjun Mahajan, John Barbieri, Evan Piette

IgA Vasculitis (IgAV) is an immune-mediated condition with limited data on its long-term prognosis in adults. This study utilized the federated TriNetX network to evaluate the incidence of cardiac, renal, and vascular complications in adults diagnosed with IgAV. After propensity score matching, 12,506 patients with IgAV and 12,506 controls were analyzed. Over 6-month, 1-year, and 3-year periods, patients with IgAV had significantly higher risks of myocardial infarction, atrial fibrillation, stroke, pulmonary embolism, venous thromboembolism, chronic kidney disease, and end-stage renal disease compared to controls. Chronic kidney disease was the most common complication, with a 3-year risk of 8.6% and the highest absolute and relative risk difference. These findings suggest that adults with IgAV may be at increased risk for serious renal and cardiovascular complications, underscoring the need for further study to determine best practices for long term monitoring and management to mitigate morbidity associated with the disease.

IgA血管炎(IgAV)是一种免疫介导的疾病,其在成人中的长期预后数据有限。本研究利用联合TriNetX网络来评估成人IgAV诊断中心脏、肾脏和血管并发症的发生率。倾向评分匹配后,对12506例IgAV患者和12506例对照进行分析。在6个月、1年和3年期间,IgAV患者发生心肌梗死、心房颤动、中风、肺栓塞、静脉血栓栓塞、慢性肾脏疾病和终末期肾脏疾病的风险明显高于对照组。慢性肾脏疾病是最常见的并发症,3年风险为8.6%,绝对和相对风险差异最大。这些研究结果表明,IgAV成人发生严重肾脏和心血管并发症的风险可能增加,强调需要进一步研究以确定长期监测和管理的最佳做法,以减轻与该疾病相关的发病率。
{"title":"Major Cardiovascular and Renal Complications in IgA Vasculitis: Insights from a Federated Health Research Network.","authors":"Arjun Mahajan, John Barbieri, Evan Piette","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>IgA Vasculitis (IgAV) is an immune-mediated condition with limited data on its long-term prognosis in adults. This study utilized the federated TriNetX network to evaluate the incidence of cardiac, renal, and vascular complications in adults diagnosed with IgAV. After propensity score matching, 12,506 patients with IgAV and 12,506 controls were analyzed. Over 6-month, 1-year, and 3-year periods, patients with IgAV had significantly higher risks of myocardial infarction, atrial fibrillation, stroke, pulmonary embolism, venous thromboembolism, chronic kidney disease, and end-stage renal disease compared to controls. Chronic kidney disease was the most common complication, with a 3-year risk of 8.6% and the highest absolute and relative risk difference. These findings suggest that adults with IgAV may be at increased risk for serious renal and cardiovascular complications, underscoring the need for further study to determine best practices for long term monitoring and management to mitigate morbidity associated with the disease.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"350-354"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI Mapping of In-House Codes to LOINC Codes Using Laboratory Test Results Excluding Test Names: Toward International Sharing of Medical Data. 使用实验室测试结果(不包括测试名称)将内部代码人工智能映射为LOINC代码:实现医疗数据的国际共享。
Noriyuki Shido, Yuma Iwahashi, Hidenari Ohsawa, Katsushige Furuya, Yasumichi Sakai, Masamichi Ishii, Hiroyuki Hoshimoto, Nobukazu Namiki, Kengo Miyo

There is an increasing demand for automatic mapping to standardized codes such as LOINC codes to create integrated medical databases across multiple facilities. However, natural language processing (NLP) in Japanese presents greater challenges than in English owing to a limited Japanese corpus for medical terms, such as test names. To address this limitation, we developed a machine learning-based method that maps in-house codes to LOINC codes by leveraging test result values without relying on test names that would require NLP. Using this approach, we achieved high mapping accuracy (70% or higher) for 80.4% of the analytes targeted in this study. The proposed method facilitates easier mapping to standardized codes in languages where NLP is challenging, ensuring accurate mapping to LOINC codes regardless of the source data language.

对自动映射到标准化代码(如LOINC代码)以创建跨多个设施的集成医疗数据库的需求越来越大。然而,由于日语医学术语(如测试名称)的日语语料库有限,日语的自然语言处理(NLP)比英语面临更大的挑战。为了解决这个限制,我们开发了一种基于机器学习的方法,通过利用测试结果值将内部代码映射到LOINC代码,而不依赖于需要NLP的测试名称。使用这种方法,我们在本研究中对80.4%的分析物实现了较高的制图精度(70%或更高)。所提出的方法便于在NLP具有挑战性的语言中更容易地映射到标准化代码,确保无论源数据语言如何都能准确映射到LOINC代码。
{"title":"AI Mapping of In-House Codes to LOINC Codes Using Laboratory Test Results Excluding Test Names: Toward International Sharing of Medical Data.","authors":"Noriyuki Shido, Yuma Iwahashi, Hidenari Ohsawa, Katsushige Furuya, Yasumichi Sakai, Masamichi Ishii, Hiroyuki Hoshimoto, Nobukazu Namiki, Kengo Miyo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There is an increasing demand for automatic mapping to standardized codes such as LOINC codes to create integrated medical databases across multiple facilities. However, natural language processing (NLP) in Japanese presents greater challenges than in English owing to a limited Japanese corpus for medical terms, such as test names. To address this limitation, we developed a machine learning-based method that maps in-house codes to LOINC codes by leveraging test result values without relying on test names that would require NLP. Using this approach, we achieved high mapping accuracy (70% or higher) for 80.4% of the analytes targeted in this study. The proposed method facilitates easier mapping to standardized codes in languages where NLP is challenging, ensuring accurate mapping to LOINC codes regardless of the source data language.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"511-517"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automatically Identifying Event Reports of Workplace Violence and Communication Failures using Large Language Models. 使用大型语言模型自动识别工作场所暴力和沟通失败事件报告。
Mike Becker, Sy Hwang, Emily Schriver, Caryn Douma, Caoimhe Duffy, Joshua Atkins, Caitlyn McShane, Jason Lubken, Asaf Hanish, John D McGreevey, Susan Harkness Regli, Danielle L Mowery

Safety event reporting forms a cornerstone of identifying and mitigating risks to patient and staff safety. However, variabilities in reporting and limited resources to analyze and classify event reports delay healthcare organizations' ability to rapidly identify safety event trends and to improve workplace safety. We demonstrated how large language models can classify safety event report narratives as workplace violence (F1: 0.80 for physical violence; F1: 0.94 for verbal abuse) and communication failures (F1: 0.94) as a first step toward enabling automated labeling of safety event reports and ultimately improving workplace safety.

安全事件报告是识别和减轻患者和工作人员安全风险的基石。然而,报告的可变性和用于分析和分类事件报告的有限资源延迟了医疗保健组织快速识别安全事件趋势和改进工作场所安全性的能力。我们证明了大型语言模型如何将安全事件报告叙述分类为工作场所暴力(身体暴力的F1: 0.80;F1: 0.94(言语虐待)和沟通失败(F1: 0.94)作为实现安全事件报告自动标记并最终改善工作场所安全的第一步。
{"title":"Automatically Identifying Event Reports of Workplace Violence and Communication Failures using Large Language Models.","authors":"Mike Becker, Sy Hwang, Emily Schriver, Caryn Douma, Caoimhe Duffy, Joshua Atkins, Caitlyn McShane, Jason Lubken, Asaf Hanish, John D McGreevey, Susan Harkness Regli, Danielle L Mowery","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Safety event reporting forms a cornerstone of identifying and mitigating risks to patient and staff safety. However, variabilities in reporting and limited resources to analyze and classify event reports delay healthcare organizations' ability to rapidly identify safety event trends and to improve workplace safety. We demonstrated how large language models can classify safety event report narratives as workplace violence (F1: 0.80 for physical violence; F1: 0.94 for verbal abuse) and communication failures (F1: 0.94) as a first step toward enabling automated labeling of safety event reports and ultimately improving workplace safety.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":"2025 ","pages":"74-83"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1